Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health.
Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health.
复制标题
DOI:
10.1111/jre.12406
复制
发表时间:
2017-06
影响因子:
3.5
通讯作者:
Miller CS
中科院分区:
文献类型:
--
作者:
Ebersole JL;Kryscio RJ;Campbell C;Kinane DF;McDevitt J;Christodoulides N;Floriano PN;Miller CS
Adiponectin is produced by adipose cells and is considered an anti-inflammatory molecule. In contrast, C-reactive protein has been identified as a hallmark of systemic inflammation and used as a risk marker of cardiovascular disease. Of interest was the relationship of these two biomarkers to oral health and cardiovascular risk. This investigation examined these two molecules in serum and unstimulated whole saliva of patients within 48 hrs. of an acute myocardial infarction (AMI) compared to control subjects. We hypothesized a differential response in these biomolecules resulting from the heart attack that would be affected by both the BMI and oral health characteristics of the individuals. Significantly lower adiponectin levels were observed in the serum of the AMI patients. Serum adiponectin in both groups and salivary adiponectin in AMI patients decreased with increasing BMI. Oral health was significantly worse in the AMI patients, and both serum and salivary adiponectin were elevated with better oral health in control subjects. Serum CRP levels were increased in the AMI patients regardless of their oral health, and both serum and salivary CRP were significantly elevated in S-T wave elevated MI patients (STEMI). These initial data provide evidence relating obesity and oral health to salivary and serum analyte levels that occur in association with cardiac events. Relationships have been described between cardiovascular (CVD) risk and periodontal disease. Additionally, various systemic inflammatory biomarkers appear to reflect both the CVD risk and the extent/severity of periodontitis. Our findings indicated that oral health and obesity contribute to altering levels of these salivary and serum analytes in association with cardiac events. The potential that serum and/or salivary biomarkers could aid in evaluating CVD risk requires knowledge regarding how the oral health of the individual would impact the effectiveness of these biological measures.